Published in J Virol on August 01, 2001
Theiler's virus infection: a model for multiple sclerosis. Clin Microbiol Rev (2004) 1.92
Innate but not adaptive immune responses contribute to behavioral seizures following viral infection. Epilepsia (2009) 1.26
Interleukin-6, produced by resident cells of the central nervous system and infiltrating cells, contributes to the development of seizures following viral infection. J Virol (2011) 1.22
Mutations that affect the tropism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenicity. J Virol (2002) 1.16
Targeting inflammatory demyelinating lesions to sites of Wallerian degeneration. Am J Pathol (2007) 1.03
Infiltrating macrophages are key to the development of seizures following virus infection. J Virol (2012) 0.98
Central nervous system pathology caused by autoreactive CD8+ T-cell clones following virus infection. J Virol (2005) 0.96
Role for complement in the development of seizures following acute viral infection. J Virol (2010) 0.94
Contrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: When can axonal injury be beneficial? Am J Pathol (2007) 0.92
TGF-beta1 suppresses T cell infiltration and VP2 puff B mutation enhances apoptosis in acute polioencephalitis induced by Theiler's virus. J Neuroimmunol (2007) 0.91
Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis. Am J Pathol (2013) 0.90
Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection. Future Virol (2008) 0.90
Regulatory role of CD1d in neurotropic virus infection. J Virol (2008) 0.87
Neurotropic viral infections leading to epilepsy: focus on Theiler's murine encephalomyelitis virus. Future Virol (2011) 0.85
Evaluating an etiologically relevant platform for therapy development for temporal lobe epilepsy: effects of carbamazepine and valproic acid on acute seizures and chronic behavioral comorbidities in the Theiler's murine encephalomyelitis virus mouse model. J Pharmacol Exp Ther (2015) 0.84
Sequential polymicrobial infections lead to CNS inflammatory disease: possible involvement of bystander activation in heterologous immunity. J Neuroimmunol (2007) 0.84
Lack of correlation of central nervous system inflammation and neuropathology with the development of seizures following acute virus infection. J Virol (2011) 0.83
Th17-biased RORγt transgenic mice become susceptible to a viral model for multiple sclerosis. Brain Behav Immun (2014) 0.83
Theiler's murine encephalomyelitis virus attachment to the gastrointestinal tract is associated with sialic acid binding. J Neurovirol (2008) 0.79
Infectious RNA isolated from the spinal cords of mice chronically infected with Theiler's murine encephalomyelitis virus. J Virol (2006) 0.79
Injection of the sciatic nerve with TMEV: a new model for peripheral nerve demyelination. Virology (2006) 0.79
RORγt, but not T-bet, overexpression exacerbates an autoimmune model for multiple sclerosis. J Neuroimmunol (2014) 0.78
Contrasting roles for Valpha14+ natural killer T cells in a viral model for multiple sclerosis. J Neurovirol (2008) 0.78
Targeting insulin-like growth factor 1 leads to amelioration of inflammatory demyelinating disease. PLoS One (2014) 0.77
NBQX, a highly selective competitive antagonist of AMPA and KA ionotropic glutamate receptors, increases seizures and mortality following picornavirus infection. Exp Neurol (2016) 0.77
DA virus mutant H101 has altered CNS pathogenesis and causes immunosuppression. J Neuroimmunol (2014) 0.75
Immunization with structural and non-structural proteins of Theiler's murine encephalomyelitis virus alters demyelinating disease. J Neurovirol (2012) 0.75
Possible role of interleukin-17 in a prime/challenge model of multiple sclerosis. J Neurovirol (2012) 0.75
Three immune-mediated disease models induced by Theiler's virus: Multiple sclerosis, seizures and myocarditis. Clin Exp Neuroimmunol (2016) 0.75
Antibody-mediated clearance of alphavirus infection from neurons. Science (1991) 3.70
Follicular dendritic cells and human immunodeficiency virus infectivity. Nature (1995) 3.22
Immunopathogenesis of Dengue hemorrhagic fever. Virology (1999) 3.16
Persistent Theiler's murine encephalomyelitis virus infection in mice depends on plaque size. J Gen Virol (1980) 3.04
Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature. J Virol (1994) 2.90
Infectious cDNA clones of the DA strain of Theiler's murine encephalomyelitis virus. J Virol (1989) 2.31
Conservation of the putative receptor attachment site in picornaviruses. Virology (1988) 1.96
Analysis of the leader and capsid coding regions of persistent and neurovirulent strains of Theiler's virus. Virology (1995) 1.72
Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J Neuropathol Exp Neurol (1996) 1.67
Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus. Crit Rev Immunol (1987) 1.65
Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system. Proc Natl Acad Sci U S A (1992) 1.60
Strains from both Theiler's virus subgroups encode a determinant for demyelination. J Virol (1990) 1.53
Three-dimensional structure of Theiler virus. Proc Natl Acad Sci U S A (1992) 1.52
Three-dimensional structure of Theiler murine encephalomyelitis virus (BeAn strain). Proc Natl Acad Sci U S A (1992) 1.50
Reversibility of the reaction between polio-virus and neutralizing antibody of rabbit origin. Virology (1961) 1.49
A single amino acid change determines persistence of a chimeric Theiler's virus. J Virol (1994) 1.42
Apoptosis in acute and chronic central nervous system disease induced by Theiler's murine encephalomyelitis virus. Virology (1997) 1.41
Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection. J Virol (1991) 1.40
Alteration of amino acid 101 within capsid protein VP-1 changes the pathogenicity of Theiler's murine encephalomyelitis virus. J Exp Med (1989) 1.39
Adaptation of Theiler's virus to L929 cells: mutations in the putative receptor binding site on the capsid map to neutralization sites and modulate viral persistence. Virology (1998) 1.36
Survival of athymic (nu/nu) mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody. J Virol (1989) 1.35
The structure of a highly virulent Theiler's murine encephalomyelitis virus (GDVII) and implications for determinants of viral persistence. Virology (1996) 1.20
Role of sialyloligosaccharide binding in Theiler's virus persistence. J Virol (1997) 1.16
Follicular dendritic cells (FDC) in retroviral infection: host/pathogen perspectives. Immunol Rev (1997) 1.16
Theiler's Murine Encephalomyelitis Virus (TMEV)-Induced Demyelination: A Model for Human Multiple Sclerosis Methods (1996) 1.15
Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA. J Neuropathol Exp Neurol (1998) 1.11
Pathogenesis of early and late disease in mice infected with Theiler's virus, using intratypic recombinant GDVII/DA viruses. J Virol (1992) 1.11
A determinant for central nervous system persistence localized in the capsid of Theiler's murine encephalomyelitis virus by using recombinant viruses. J Virol (1998) 1.10
Hydrocephalus in mice infected with a Theiler's murine encephalomyelitis virus variant. J Neuropathol Exp Neurol (1997) 1.09
Three-dimensional model of the capsid proteins of two biologically different Theiler virus strains: clustering of amino acid difference identifies possible locations of immunogenic sites on the virion. Proc Natl Acad Sci U S A (1988) 1.08
A comparative study of acute and chronic diseases induced by two subgroups of Theiler's murine encephalomyelitis virus. Acta Neuropathol (1996) 1.08
Viral infection and dissemination through the olfactory pathway and the limbic system by Theiler's virus. Am J Pathol (1993) 1.07
Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus-induced disease. J Virol (1994) 1.05
Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA. Brain Pathol (1999) 1.04
Analysis of antibody responses to predominant linear epitopes of Theiler's murine encephalomyelitis virus. J Virol (1994) 1.04
Protection of SJL/J mice from demyelinating disease mediated by Theiler's murine encephalomyelitis virus. Microb Pathog (1995) 1.00
A neutralization site of DA strain of Theiler's murine encephalomyelitis virus important for disease phenotype. Virology (1996) 0.98
Theiler's viruses with mutations in loop I of VP1 lead to altered tropism and pathogenesis. J Virol (1999) 0.98
Role of VP2 amino acid 141 in tropism of Theiler's virus within the central nervous system. J Virol (1996) 0.89
The growth of four human and animal enteroviruses in the central nervous systems of mice. J Neuropathol Exp Neurol (1981) 0.89
Chronic Theiler's virus infection in mice: appearance of myelin basic protein in the cerebrospinal fluid and serum antibody directed against MBP. J Neuroimmunol (1987) 0.88
DNA vaccination against Theiler's murine encephalomyelitis virus leads to alterations in demyelinating disease. J Virol (1999) 0.88
Molecular characterization of a nondemyelinating variant of Daniel's strain of Theiler's virus isolated from a persistently infected glioma cell line. J Virol (1998) 0.88
Molecular determinants of Theiler's murine encephalomyelitis-induced disease. J Neurovirol (1996) 0.88
The course of disease and persistence of virus in the central nervous system varies between individual CBA mice infected with the BeAn strain of Theiler's murine encephalomyelitis virus. J Gen Virol (1996) 0.84
Human immunodeficiency virus. Trapped but still dangerous. Nature (1995) 0.78
Specific infection and destruction of dopaminergic neurons in the substantia nigra by Theiler's virus. J Virol (1997) 0.77
Neutralization of Theiler's virus. Acta Pathol Microbiol Scand (1955) 0.77
Novel system for monitoring autophagy in the yeast Saccharomyces cerevisiae. Biochem Biophys Res Commun (1995) 5.89
A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature (1997) 5.55
Apg1p, a novel protein kinase required for the autophagic process in Saccharomyces cerevisiae. Gene (1997) 5.53
Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains. Nucleic Acids Res (2000) 4.34
Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science (1985) 3.68
Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation (1997) 3.04
Codon usage tabulated from the GenBank genetic sequence data. Nucleic Acids Res (1991) 3.01
Codon usage tabulated from the GenBank genetic sequence data. Nucleic Acids Res (1992) 2.95
Mechanical rotation of the c subunit oligomer in ATP synthase (F0F1): direct observation. Science (1999) 2.92
Direct comparison of GeneChip and SAGE on the quantitative accuracy in transcript profiling analysis. Genomics (2000) 2.14
Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci U S A (1983) 2.12
Structural and functional analyses of APG5, a gene involved in autophagy in yeast. Gene (1996) 2.06
PCR on cerebrospinal fluid to show influenza-associated acute encephalopathy or encephalitis. Lancet (1998) 2.02
Vam2/Vps41p and Vam6/Vps39p are components of a protein complex on the vacuolar membranes and involved in the vacuolar assembly in the yeast Saccharomyces cerevisiae. J Biol Chem (1997) 1.97
Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. J Mol Cell Cardiol (2001) 1.92
Central pontine myelinolysis associated with hypokalaemia in anorexia nervosa. J Neurol Neurosurg Psychiatry (2003) 1.78
Structure of the C-terminal domain of FliG, a component of the rotor in the bacterial flagellar motor. Nature (1999) 1.76
Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell. Nature (1979) 1.75
Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J Neuropathol Exp Neurol (1996) 1.67
Deterioration of long-term clinical results after the Elmslie-Trillat procedure for dislocation of the patella. J Bone Joint Surg Br (2002) 1.64
cis Element decoy against nuclear factor-kappaB attenuates development of experimental autoimmune myocarditis in rats. Circ Res (2001) 1.60
Sensing of cadmium and copper ions by externally exposed ADL, ASE, and ASH neurons elicits avoidance response in Caenorhabditis elegans. Neuroreport (1999) 1.60
The AtVAM3 encodes a syntaxin-related molecule implicated in the vacuolar assembly in Arabidopsis thaliana. J Biol Chem (1997) 1.60
A neutralization-resistant Theiler's virus variant produces an altered disease pattern in the mouse central nervous system. J Virol (1989) 1.59
Acidification of vacuoles is required for autophagic degradation in the yeast, Saccharomyces cerevisiae. J Biochem (1997) 1.57
Structure of the proteasome activator REGalpha (PA28alpha). Nature (1997) 1.56
Remodeling of cell-cell and cell-extracellular matrix interactions at the border zone of rat myocardial infarcts. Circ Res (1999) 1.55
Human SPA-1 gene product selectively expressed in lymphoid tissues is a specific GTPase-activating protein for Rap1 and Rap2. Segregate expression profiles from a rap1GAP gene product. J Biol Chem (1997) 1.54
Charged collagen structure mediates the recognition of negatively charged macromolecules by macrophage scavenger receptors. J Biol Chem (1993) 1.53
Mechanism of Theiler's virus-induced demyelination in nude mice. Lab Invest (1986) 1.53
Three-dimensional structure of Theiler virus. Proc Natl Acad Sci U S A (1992) 1.52
Codon usage tabulated from the international DNA sequence databases. Nucleic Acids Res (1996) 1.49
Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's disease. Biochem Biophys Res Commun (1991) 1.49
Hereditary nodular heterotopia accompanied by mega cisterna magna. Am J Med Genet (1993) 1.48
Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater. Jpn J Cancer Res (1994) 1.48
Theoretical approach to the epidemiology of onchocerciasis in Guatemala. Jpn J Med Sci Biol (1982) 1.48
Caveolae in mesangial cells and caveolin expression in mesangial proliferative glomerulonephritis. Kidney Int (2001) 1.47
Infection with vaccinia favors the selection of hybridomas synthesizing autoantibodies against intermediate filaments, one of them cross-reacting with the virus hemagglutinin. J Immunol (1983) 1.46
Alterations in expression of measles virus polypeptides by antibody: molecular events in antibody-induced antigenic modulation. J Immunol (1980) 1.45
Degeneration of patellar cartilage in patients with recurrent patellar dislocation following conservative treatment: evaluation with delayed gadolinium-enhanced magnetic resonance imaging of cartilage. Osteoarthritis Cartilage (2009) 1.45
Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun (1996) 1.42
Apoptosis in acute and chronic central nervous system disease induced by Theiler's murine encephalomyelitis virus. Virology (1997) 1.41
Theiler's virus infection in nude mice: viral RNA in vascular endothelial cells. J Virol (1988) 1.41
Three subunit a isoforms of mouse vacuolar H(+)-ATPase. Preferential expression of the a3 isoform during osteoclast differentiation. J Biol Chem (2000) 1.40
Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection. J Virol (1991) 1.40
Alteration of amino acid 101 within capsid protein VP-1 changes the pathogenicity of Theiler's murine encephalomyelitis virus. J Exp Med (1989) 1.39
Identifying pathogenic genetic background of simplex or multiplex retinitis pigmentosa patients: a large scale mutation screening study. J Med Genet (2008) 1.38
Four subunit a isoforms of Caenorhabditis elegans vacuolar H+-ATPase. Cell-specific expression during development. J Biol Chem (2001) 1.36
Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy. J Mol Cell Cardiol (2000) 1.35
Mitochondrial DNA mutations in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Biochem Biophys Res Commun (1991) 1.34
Structure, organization, and chromosomal mapping of the human macrophage scavenger receptor gene. J Biol Chem (1993) 1.32
Fibroblasts expressing Sonic hedgehog induce osteoblast differentiation and ectopic bone formation. FEBS Lett (1997) 1.31
The gamma-subunit rotation and torque generation in F1-ATPase from wild-type or uncoupled mutant Escherichia coli. Proc Natl Acad Sci U S A (1999) 1.29
Syntaxin 7 mediates endocytic trafficking to late endosomes. J Biol Chem (2000) 1.29
Adult-onset spinocerebellar syndrome with idiopathic vitamin E deficiency. Ann Neurol (1987) 1.27
Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology (1996) 1.24
Viruses disrupt functions of human lymphocytes. II. Measles virus suppresses antibody production by acting on B lymphocytes. J Exp Med (1986) 1.24
Crystal structure of human uroporphyrinogen III synthase. EMBO J (2001) 1.23
Mitochondrial DNA determines androgen dependence in prostate cancer cell lines. Oncogene (2006) 1.23
Acidic amino acid-rich sequences as binding sites of osteonectin to hydroxyapatite crystals. Biochim Biophys Acta (1996) 1.22
Autosomal dominant cone-rod dystrophy associated with mutations in codon 244 (Asn244His) and codon 184 (Tyr184Ser) of the peripherin/RDS gene. Arch Ophthalmol (1996) 1.22
Mitotic activity in mice is suppressed by energy restriction-induced torpor. J Nutr (1992) 1.21
Individual trait anxiety levels characterizing the properties of zen meditation. Neuropsychobiology (2004) 1.21
Visuospatial imagery is a fruitful strategy for the digit span backward task: a study with near-infrared optical tomography. Brain Res Cogn Brain Res (2000) 1.21
Differential amygdala response during facial recognition in patients with schizophrenia: an fMRI study. Schizophr Res (2002) 1.20
The relationship between viral RNA, myelin-specific mRNAs, and demyelination in central nervous system disease during Theiler's virus infection. Am J Pathol (1990) 1.20
Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency. Hum Mol Genet (1999) 1.19
Virus-induced immunosuppression: infection of peripheral blood mononuclear cells and suppression of immunoglobulin synthesis during natural measles virus infection of rhesus monkeys. J Infect Dis (1989) 1.19
Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int (1997) 1.18
Antibody association with a novel model for primary progressive multiple sclerosis: induction of relapsing-remitting and progressive forms of EAE in H2s mouse strains. Brain Pathol (2000) 1.17
Identification of novel mutations in the dihydropyrimidine dehydrogenase gene in a Japanese patient with 5-fluorouracil toxicity. Clin Cancer Res (1998) 1.16
Therapeutic effects of imidazolineoxyl N-oxide against endotoxin shock through its direct nitric oxide-scavenging activity. Biochem Biophys Res Commun (1994) 1.15
Characterization of in vitro transcription and transcriptional products of measles virus. J Virol (1987) 1.14
Failure to cleave measles virus fusion protein in lymphoid cells. J Exp Med (1981) 1.13
Homozygosity mapping to chromosome 5p15 of a gene responsible for Hartnup disorder. Biochem Biophys Res Commun (2001) 1.12
Caenorhabditis elegans senses protons through amphid chemosensory neurons: proton signals elicit avoidance behavior. Neuroreport (2000) 1.12
Endoscopic in vivo evaluation of tissue atypia in the esophagus using a newly designed integrated endocytoscope: a pilot trial. Endoscopy (2006) 1.12
Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA. J Neuropathol Exp Neurol (1998) 1.11
The 11S regulators of 20S proteasome activity. Curr Top Microbiol Immunol (2002) 1.11
Vulnerability to cerebral hypoxic-ischemic insult in neonatal but not in adult rats is in parallel with disruption of the blood-brain barrier. Stroke (1997) 1.10
CT evaluation of hepatic tumors: comparison of CT with arterial portography, CT with infusion hepatic arteriography, and simultaneous use of both techniques. AJR Am J Roentgenol (1995) 1.09
Calculated two-dimensional sugar map of pyridylaminated oligosaccharides: elucidation of the jack bean alpha-mannosidase digestion pathway of Man9GlcNAc2. Anal Biochem (1991) 1.09
Hydrocephalus in mice infected with a Theiler's murine encephalomyelitis virus variant. J Neuropathol Exp Neurol (1997) 1.09
Human neuroblastomas with unfavorable biologies express high levels of brain-derived neurotrophic factor mRNA and a variety of its variants. Cancer Lett (2001) 1.08
Cloning of the human erythropoietin receptor gene. Blood (1991) 1.08
Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis. J Exp Med (1990) 1.08
Mapping of the major histocompatibility complex and viral antigens on the plasma membrane of a measles virus-infected cell. Virology (1983) 1.07
Viral infection and dissemination through the olfactory pathway and the limbic system by Theiler's virus. Am J Pathol (1993) 1.07
a4, a unique kidney-specific isoform of mouse vacuolar H+-ATPase subunit a. J Biol Chem (2001) 1.07
Mutagenic analysis of functional residues in putative substrate-binding site and acidic domains of vacuolar H+-pyrophosphatase. J Biol Chem (2000) 1.06
A neo-Darwinian algorithm: asymmetrical mutations due to semiconservative DNA-type replication promote evolution. Proc Natl Acad Sci U S A (1993) 1.06
Combined hepatocellular and cholangiocarcinoma: correlation between CT findings and clinicopathological features. J Comput Assist Tomogr (1997) 1.05
Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population. Cancer Res (2000) 1.05
Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus-induced disease. J Virol (1994) 1.05
Tumor growth inhibitory activity of a lymphocyte blastogenesis inhibitory factor. Cancer Res (1990) 1.05
Characterization of apolipoprotein-mediated HDL generation induced by cAMP in a murine macrophage cell line. Biochemistry (2000) 1.04
Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA. Brain Pathol (1999) 1.04
A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis. Cancer Res (2001) 1.03
Restricted virus replication in the spinal cords of nude mice infected with a Theiler's virus variant. J Virol (1991) 1.03
Acidic endomembrane organelles are required for mouse postimplantation development. Dev Biol (2000) 1.03